Lihui Wu1, Zhifei Xu, Xuewei Zhao, Jianqiu Li, Lei Zhong, Tieweng Pang, Bin Wu. 1. Department of Cardiothoracic Surgery, Changzheng Hospital, Second Military Medical University, 415 Fengyang Road, Shanghai 200003, People's Republic of China. dr_wulihui@yahoo.com.cn
Abstract
BACKGROUND: The purpose of the present study was to explore the efficacy of an extended operation for locally advanced non-small cell lung cancer invading the left atrium and intrapericardial pulmonary vein. METHODS: From January 2000 to January 2006, lobectomy or pneumonectomy combined with extended resection of the left atrium was carried out in 46 patients. The operations included left lower lobectomy in 6 cases, left pneumonectomy in 14 cases, right middle and lower lobectomy in 8 cases, right lower lobectomy in 2 cases, and right pneumonectomy in 16 cases; these cases accounted for 4.9% of the lung cancer patients who underwent surgical treatment in the Changzheng Hospital, Second Military Medical University, during the study period. RESULTS: There were no surgery-related deaths, and the overall 1-, 3-, and 5-year survival rates were 71.77%, 37.79%, and 22.04%, respectively; the 1-, 3-, and 5-year survival rates of patients with no lymph node involvement (N0) were 77.16%, 43.40%, and 28.94%, respectively; the 1-, 3-, and 5-year survival rates of N1 patients were 75.94%, 41.88%, and 27.92%, respectively; the 1- and 3-year survival rates of N2 patients were 53.85% and 17.95%, respectively. CONCLUSIONS: Surgical treatment of T4 lung cancer invading the left atrium or the base of the pulmonary vein is feasible, particularly in N0 and N1 patients with a < or =3 cm maximum diameter of primary lung cancer. It can improve the quality of life and increase long-term survival. Surgical management should be considered in selected lung cancer patients.
BACKGROUND: The purpose of the present study was to explore the efficacy of an extended operation for locally advanced non-small cell lung cancer invading the left atrium and intrapericardial pulmonary vein. METHODS: From January 2000 to January 2006, lobectomy or pneumonectomy combined with extended resection of the left atrium was carried out in 46 patients. The operations included left lower lobectomy in 6 cases, left pneumonectomy in 14 cases, right middle and lower lobectomy in 8 cases, right lower lobectomy in 2 cases, and right pneumonectomy in 16 cases; these cases accounted for 4.9% of the lung cancerpatients who underwent surgical treatment in the Changzheng Hospital, Second Military Medical University, during the study period. RESULTS: There were no surgery-related deaths, and the overall 1-, 3-, and 5-year survival rates were 71.77%, 37.79%, and 22.04%, respectively; the 1-, 3-, and 5-year survival rates of patients with no lymph node involvement (N0) were 77.16%, 43.40%, and 28.94%, respectively; the 1-, 3-, and 5-year survival rates of N1 patients were 75.94%, 41.88%, and 27.92%, respectively; the 1- and 3-year survival rates of N2 patients were 53.85% and 17.95%, respectively. CONCLUSIONS: Surgical treatment of T4 lung cancer invading the left atrium or the base of the pulmonary vein is feasible, particularly in N0 and N1 patients with a < or =3 cm maximum diameter of primary lung cancer. It can improve the quality of life and increase long-term survival. Surgical management should be considered in selected lung cancerpatients.
Authors: Anna C Pfannenberg; Philip Aschoff; Klaus Brechtel; Mark Müller; Roland Bares; Frank Paulsen; Jutta Scheiderbauer; Godehard Friedel; Claus D Claussen; Susanne M Eschmann Journal: Eur J Nucl Med Mol Imaging Date: 2006-08-01 Impact factor: 9.236
Authors: Lorenzo Spaggiari; Massimiliano D' Aiuto; Giulia Veronesi; Giuseppe Pelosi; Tommaso de Pas; Gianpiero Catalano; Filippo de Braud Journal: Ann Thorac Surg Date: 2005-01 Impact factor: 4.330
Authors: Eric E Roselli; Sudish C Murthy; Thomas W Rice; Penny L Houghtaling; Christopher D Pierce; Daniel P Karchmer; Eugene H Blackstone Journal: J Thorac Cardiovasc Surg Date: 2005-08 Impact factor: 5.209
Authors: Giovanni B Ratto; Roberta Costa; Giuseppe Vassallo; Antonella Alloisio; Paola Maineri; Paolo Bruzzi Journal: Ann Thorac Surg Date: 2004-07 Impact factor: 4.330
Authors: Shadi Hamouri; Nasr Alrabadi; Sebawe Syaj; Hassan Abushukair; Obada Ababneh; Leen Al-Kraimeen; Majd Al-Sous; Erich Hecker Journal: Surg Today Date: 2022-01-09 Impact factor: 2.549
Authors: Manzar Abbas; Usama Qamar; Syeda Maria Ahmad Zaidi; Faiqa Binte Aamir; Ali Aahil Noorali; Haseeb Ur Rahman; Saulat Hasnain Fatimi Journal: JTO Clin Res Rep Date: 2022-01-21